FREQUENCY OF RESPONSIBLE FACTORS FOR PERIPARTUM CARDIOMYOPATHY IN PATIENT PRESENTING TO GYNEA DEPARTMENT READING HOSPITAL PESHAWAR
Main Article Content
Keywords
responsible factors, peripartum cardiomyopathy
Abstract
Background: When there is no other known cause of heart failure, peripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy that manifests as heart failure due to left ventricular (LV) systolic malfunction around the end of pregnancy or in the months after delivery.
Objective: To determine the frequency of responsible factors for peripartum cardiomyopathy in patient presenting to Gynae department of Lady Reading Hospital, Peshawar.
Material and Methods: This descriptive cross-sectional study was conducted in the Department of Obstetrics and Gynecology at Lady Reading Hospital, Peshawar, over a duration of six months from January 27, 2020, to July 27, 2020. Clinical examination and routine investigation like echo was performed for the confirmation of PPCM. Echo test was performed in the cardiology department under the supervision of expert cardiologist having at least five years of experience. All the data were analyzed in SPSS version 16.
Results: A total of 247 patients were observed with mean age was 33 years with SD± 12.84. 66% patients had gestational age 37-38 weeks and 34% patients had gestational age 39-40 weeks. 18% patients were primi para and 82% patients were multi para. More over responsible factors for peripartum cardiomyopathy were pregnancy induced hypertension 67(27%), Preeclampsia 109(44%) and Type 2 diabetes mellitus was 30(12%).
Conclusion: Our study concludes that responsible factors for peripartum cardiomyopathy were pregnancy induced hypertension 27%, Preeclampsia 44%, and Type 2 diabetes mellitus was 12%.
References
2. Ivey SL, Hanley HR, Taylor C, Stock E, Vora N, Woo J, et al. Early identification and treatment of women’s cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers. Clin Cardiol. 2022 Nov 20;45(11):1100–6.
3. Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, et al. Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population‐Based Study. J Am Heart Assoc. 2014 May 22;3(3).
4. Kao DP, Hsich E, Lindenfeld J. Characteristics, Adverse Events, and Racial Differences Among Delivering Mothers With Peripartum Cardiomyopathy. JACC Hear Fail. 2013 Oct;1(5):409–16.
5. Wu VCC, Chen TH, Yeh JK, Wu M, Lu CH, Chen SW, et al. Clinical outcomes of peripartum cardiomyopathy. Medicine (Baltimore). 2017 Oct;96(43):e8374.
6. Bello N, Rendon ISH, Arany Z. The Relationship Between Pre-Eclampsia and Peripartum Cardiomyopathy. J Am Coll Cardiol. 2013 Oct;62(18):1715–23.
7. Munir R, Hussain S, Kayani AM. Peripartum Cardiomyopathy in a Pakistani Cohort. J Coll Physicians Surg Pak. 2016 Sep;26(9):740–3.
8. Gunaydin ZY, Gurel YE, Erdogan G, Kaya A. Peripartum cardiomyopathy associated with triplet pregnancy. Anadolu Kardiyol Dergisi/The Anatol J Cardiol. 2014 Nov 13;14(7):661–2.
9. Elkayam U. Risk of Subsequent Pregnancy in Women With a History of Peripartum Cardiomyopathy. J Am Coll Cardiol. 2014 Oct;64(15):1629–36.
10. Iorgoveanu C, Zaghloul A, Ashwath M. Peripartum cardiomyopathy: a review. Heart Fail Rev. 2021 Nov 17;26(6):1287–96.
11. Rantner B, Pohlhammer J, Stadler M, Peric S, Hammerer-Lercher A, Klein-Weigel P, et al. Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication – results from the CAVASIC Study. Atherosclerosis. 2015 Apr;239(2):428–35.
12. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: A comprehensive review. Int J Cardiol. 2007 Jun;118(3):295–303.
13. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JDH, Paulus WJ, et al. Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy. Circulation. 2010 May 25;121(20):2169–75.
14. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, et al. A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy. Cell. 2007 Feb;128(3):589–600.
15. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol. 2000 Mar;35(3):701–5.
16. Fett JD, Ansari AA. Inflammatory markers and cytokines in peripartum cardiomyopathy: a delicate balance. Expert Opin Ther Targets. 2010 Sep 29;14(9):895–8.
17. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy- Associated Cardiomyopathy. Circulation. 2005 Apr 26;111(16):2050–5.
18. Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL. African-American Women Have a Higher Risk for Developing Peripartum Cardiomyopathy. J Am Coll Cardiol. 2010 Feb;55(7):654–9.
19. Tang L, Liu Y, Wang Y, Long C. Phytochemical analysis of an antiviral fraction of Radix astragali using HPLC–DAD–ESI–MS/MS. J Nat Med. 2010 Apr 29;64(2):182– 6.